| Malignant disease | |||||
|---|---|---|---|---|---|
| Malignant disease / Antibody responsive malignancy | |||||
| atezolizumab | On Formulary |
NICE TA525 NICE TA739 NICE TA520 NICE TA584 NICE TA705 NICE TA823 NICE TA638 NICE TA639 NICE TA666 |
|||
| Solution for infusion | |||||
| Tecentriq (Roche Products Ltd) | On Formulary | ||||
| bevacizumab |
NICE TA118 NICE TA212 NICE TA242 NICE TA178 NICE TA214 NICE TA263 NICE TA284 NICE TA285 NICE TA666 NICE TA693 |
||||
| Solution for infusion | |||||
| Avastin (Roche Products Ltd) | Restricted | ||||
| brentuximab vedotin | On Formulary |
NICE TA478 NICE TA641 NICE TA524 NICE TA577 |
|||
| cetuximab |
NICE TA145 NICE TA473 NICE TA242 NICE TA439 NICE TA668 |
||||
| Solution for infusion | |||||
| Erbitux (Merck Serono Ltd) | On Formulary | ||||
| obinutuzumab |
NICE TA343 NICE TA513 NICE TA629 |
||||
| Solution for infusion | |||||
| Gazyvaro (Roche Products Ltd) | On Formulary | ||||
| pertuzumab |
NICE TA424 NICE TA509 NICE TA569 |
||||
| Solution for infusion | |||||
| Perjeta (Roche Products Ltd) | On Formulary | ||||
| rituximab |
NICE TA308 NICE TA195 NICE TA243 NICE TA137 NICE TA193 NICE TA226 NICE TA174 NICE TA359 NICE TA561 |
||||
| Solution for infusion | |||||
| Truxima (Celltrion Healthcare UK Ltd) | On Formulary | ||||
| trastuzumab emtansine | On Formulary |
NICE TA458 NICE TA632 |
|||
| Malignant disease / Immunotherapy responsive malignancy | |||||
| Bacillus Calmette-Guérin | On Formulary | ||||
| lenalidomide | On Formulary |
NICE TA322 NICE TA171 NICE TA505 NICE TA586 NICE TA587 NICE TA627 NICE TA680 |
|||
| Capsule | |||||
| Revlimid (Bristol-Myers Squibb Pharmaceuticals Ltd) | On Formulary | ||||
| thalidomide | On Formulary |
NICE TA228 |
|||
| Capsule | |||||
| Thalidomide (Non-proprietary) | On Formulary | ||||
| Malignant disease / Targeted therapy responsive malignancy | |||||
| axitinib |
NICE TA333 NICE TA645 NICE TA650 |
||||
| Tablet | |||||
| Inlyta (Pfizer Ltd) | Restricted | ||||
| bortezomib |
NICE TA370 NICE TA311 NICE TA228 NICE TA129 |
||||
| Powder for solution for injection | |||||
| Velcade (Janssen-Cilag Ltd) | Restricted | ||||
| bosutinib |
NICE TA401 |
||||
| Tablet | |||||
| Bosulif (Pfizer Ltd) | On Formulary | ||||
| crizotinib |
NICE TA406 NICE TA422 NICE TA529 |
||||
| Capsule | |||||
| Xalkori (Pfizer Ltd) | On Formulary | ||||
| dasatinib |
NICE TA426 NICE TA425 |
||||
| Tablet | |||||
| Sprycel (Bristol-Myers Squibb Pharmaceuticals Ltd) | On Formulary | ||||
| erlotinib |
NICE TA227 NICE TA258 NICE TA374 NICE TA374 |
||||
| Tablet | |||||
| Tarceva (Roche Products Ltd) | On Formulary | ||||
| everolimus |
NICE TA421 NICE TA432 NICE TA449 |
||||
|
Afinitor® NICE TA498 Certican® NICE TA348 Certican® NICE TA481 |
|||||
| Tablet | |||||
| Afinitor (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
| gefitinib |
NICE TA192 NICE TA374 |
||||
| Tablet | |||||
| Iressa (AstraZeneca UK Ltd) | On Formulary | ||||
| imatinib |
NICE TA326 NICE TA70 NICE TA86 NICE TA209 NICE TA426 NICE TA425 |
||||
| Tablet | |||||
| Glivec (Novartis Pharmaceuticals UK Ltd) | Restricted | ||||
| lapatinib |
NICE TA257 |
||||
| Tablet | |||||
| Tyverb (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
| nilotinib |
NICE TA426 NICE TA425 |
||||
| Capsule | |||||
| Tasigna (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
| palbociclib | On Formulary |
NICE TA495 NICE TA836 |
|||
| ponatinib |
NICE TA451 |
||||
| Tablet | |||||
| Iclusig (Incyte Biosciences UK Ltd) | On Formulary | ||||
| ribociclib |
NICE TA496 NICE TA687 |
||||
| Tablet | |||||
| Kisqali (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
| ruxolitinib |
NICE TA386 |
||||
| Tablet | |||||
| Jakavi (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
| sorafenib |
NICE TA178 NICE TA474 NICE TA535 |
||||
| Tablet | |||||
| Nexavar (Bayer Plc) | On Formulary | ||||
| Malignant disease / Cytotoxic responsive malignancy | |||||
| cabazitaxel |
NICE TA391 |
||||
| Solution for infusion | |||||
| Jevtana (Sanofi Genzyme) | On Formulary | ||||
| carboplatin |
NICE TA284 NICE TA285 |
||||
| Solution for infusion | |||||
| Carboplatin (Non-proprietary) | On Formulary | ||||
| cisplatin | |||||
| Solution for infusion | |||||
| Cisplatin (Non-proprietary) | On Formulary | ||||
| cladribine |
NICE TA616 |
||||
| Solution for injection | |||||
| Litak (Lipomed GmbH) | On Formulary | ||||
| Solution for infusion | |||||
| Leustat (Atnahs Pharma UK Ltd) | On Formulary | ||||
| cyclophosphamide | |||||
| Tablet | |||||
| Cyclophosphamide (Non-proprietary) | On Formulary | ||||
| Powder for solution for injection | |||||
| Cyclophosphamide (Non-proprietary) | On Formulary | ||||
| cytarabine | |||||
| Solution for injection | |||||
| Cytarabine (Non-proprietary) | On Formulary | ||||
| epirubicin hydrochloride | |||||
| Solution for infusion | |||||
| Pharmorubicin (Pfizer Ltd) | On Formulary | ||||
| eribulin |
NICE TA423 NICE TA515 |
||||
| Solution for injection | |||||
| Halaven (Eisai Ltd) | On Formulary | ||||
| estramustine phosphate | |||||
| Capsule | |||||
| Estracyt (Pfizer Ltd) | On Formulary | ||||
| etoposide | |||||
| Capsule | |||||
| Vepesid (Neon Healthcare Ltd) | On Formulary | ||||
| Solution for infusion | |||||
| Etoposide (Non-proprietary) | On Formulary | ||||
| fluorouracil | |||||
| Solution for injection | |||||
| Fluorouracil (Non-proprietary) | On Formulary | ||||
| Solution for infusion | |||||
| Fluorouracil (Non-proprietary) | On Formulary | ||||
| hydroxycarbamide | |||||
| Capsule | |||||
| Hydroxycarbamide (Non-proprietary) | On Formulary | ||||
| ifosfamide | |||||
| Powder for solution for injection | |||||
| Ifosfamide (Non-proprietary) | On Formulary | ||||
| lomustine | |||||
| Capsule | |||||
| Lomustine (Non-proprietary) | On Formulary | ||||
| mercaptopurine | |||||
| Tablet | |||||
| Mercaptopurine (Non-proprietary) | On Formulary | ||||
| methotrexate | |||||
| Tablet | |||||
| Methotrexate (Non-proprietary) | On Formulary | ||||
| Maxtrex (Pfizer Ltd) | On Formulary | ||||
| Solution for injection | |||||
| Methotrexate (Non-proprietary) | On Formulary | ||||
| Metoject PEN (medac UK) | On Formulary | ||||
| Solution for infusion | |||||
| Methotrexate (Non-proprietary) | On Formulary | ||||
| procarbazine | |||||
| Capsule | |||||
| Procarbazine (Non-proprietary) | On Formulary | ||||
| vinblastine sulfate | |||||
| Solution for injection | |||||
| Vinblastine sulfate (Non-proprietary) | On Formulary | ||||
| vincristine sulfate | |||||
| Solution for injection | |||||
| Vincristine sulfate (Non-proprietary) | On Formulary | ||||
| Malignant disease / Cytotoxic drug-induced side effects | |||||
| folinic acid | On Formulary |
NICE TA212 |
|||
| mesna | On Formulary | ||||
| Malignant disease / Hyperuricaemia associated with cytotoxic drugs | |||||
| allopurinol | On Formulary | ||||
| Malignant disease / Hormone responsive malignancy | |||||
| bicalutamide | On Formulary | ||||
| Tablet | |||||
| Bicalutamide (Non-proprietary) | On Formulary | ||||
| cyproterone acetate | On Formulary | ||||
| Tablet | |||||
| Cyproterone acetate (Non-proprietary) | On Formulary | ||||
| Cyprostat (Bayer Plc) | On Formulary | ||||
| degarelix |
NICE TA404 |
||||
| Powder and solvent for solution for injection | |||||
| Firmagon (Ferring Pharmaceuticals Ltd) | Restricted | ||||
| diethylstilbestrol | |||||
| Tablet | |||||
| Diethylstilbestrol (Non-proprietary) | On Formulary | ||||
| flutamide | |||||
| Tablet | |||||
| Flutamide (Non-proprietary) | On Formulary | ||||
| goserelin | On Formulary | ||||
| Implant | |||||
| Zoladex (AstraZeneca UK Ltd) | On Formulary | ||||
| Zoladex LA (AstraZeneca UK Ltd) | On Formulary | ||||
| lanreotide | Restricted | ||||
| leuprorelin acetate | On Formulary | ||||
| Powder and solvent for suspension for injection | |||||
| Prostap SR DCS (Takeda UK Ltd) | On Formulary | ||||
| medroxyprogesterone acetate | |||||
| Tablet | |||||
| Provera (Pfizer Ltd) | On Formulary | ||||
| megestrol acetate | |||||
| Tablet | |||||
| Megace (Bausch & Lomb UK Ltd) | On Formulary | ||||
| norethisterone | |||||
| Tablet | |||||
| Norethisterone (Non-proprietary) | On Formulary | ||||
| Primolut N (Bayer Plc) | On Formulary | ||||
| Utovlan (Pfizer Ltd) | On Formulary | ||||
| octreotide | On Formulary | ||||
| Solution for injection | |||||
| Octreotide (Non-proprietary) | On Formulary | ||||
| Sandostatin (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
| Powder and solvent for suspension for injection | |||||
| Sandostatin LAR (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
| triptorelin | On Formulary | ||||
| Powder and solvent for suspension for injection | |||||
| Decapeptyl SR (Ipsen Ltd) | On Formulary | ||||
| Gonapeptyl Depot (Ferring Pharmaceuticals Ltd) | On Formulary | ||||
| Malignant disease / Hormone responsive breast cancer | |||||
| anastrozole | On Formulary | ||||
| Tablet | |||||
| Anastrozole (Non-proprietary) | On Formulary | ||||
| Arimidex (AstraZeneca UK Ltd) | On Formulary | ||||
| exemestane | On Formulary | ||||
| Tablet | |||||
| Aromasin (Pfizer Ltd) | Restricted | ||||
| fulvestrant | On Formulary |
NICE TA503 |
|||
| letrozole | On Formulary | ||||
| Tablet | |||||
| Femara (Novartis Pharmaceuticals UK Ltd) | Restricted | ||||
| tamoxifen | On Formulary | ||||
| Tablet | |||||
| Tamoxifen (Non-proprietary) | On Formulary | ||||
| Oral solution | |||||
| Tamoxifen (Non-proprietary) | On Formulary | ||||
| Malignant disease / Secondary bone metastases and hypercalcaemia | |||||
| calcitonin (salmon) | On Formulary | ||||
| Solution for injection | |||||
| Calcitonin (salmon) (Non-proprietary) | On Formulary | ||||
| denosumab | On Formulary |
NICE TA204 NICE TA265 |
|||
| Solution for injection | |||||
| Prolia (Amgen Ltd) | On Formulary | ||||
| Xgeva (Amgen Ltd) | On Formulary | ||||
| pamidronate disodium | On Formulary | ||||
| Solution for infusion | |||||
| Pamidronate disodium (Non-proprietary) | On Formulary | ||||
| sodium clodronate | On Formulary | ||||
| zoledronic acid | Restricted |
NICE TA464 |
|||
| Infusion | |||||
| Aclasta (Novartis Pharmaceuticals UK Ltd) | Restricted | ||||
| Zometa (Novartis Pharmaceuticals UK Ltd) | Restricted | ||||